mab
subclass
mab
subclass
strong
ade
activ
furthermor
mab
show
strong
neutral
activ
feli
catu
whole
fetu
cell
crandel
felin
kidney
crfk
cell
show
strong
enhanc
activ
felin
macrophag
indic
neutral
epitop
enhanc
epitop
close
relat
studi
prepar
mab
show
strong
neutral
activ
felin
macrophag
despit
fact
mab
belong
subclass
howev
mab
exhibit
neutral
activ
crfk
cell
cell
thu
show
unusu
properti
mab
recogn
fipv
small
integr
membran
glycoprotein
protein
even
felin
macrophag
pretreat
mab
prior
fipv
inocul
antibodi
prevent
fipv
infect
reaction
disappear
treatment
protein
neutral
activ
also
effect
felin
macrophag
cell
inocul
fipv
find
indic
fipv
replic
mechan
differ
felin
macrophag
cell
neutral
epitop
prevent
fipv
infect
felin
macrophag
viral
absorpt
present
protein
felin
infecti
periton
fip
virusinduc
diseas
chronic
progress
usual
fatal
diseas
domest
wild
felida
caus
agent
diseas
fip
viru
fipv
belong
famili
coronavirida
genu
coronaviru
field
felin
enter
coronaviru
fecv
also
preval
fecv
antigen
similar
fipv
infect
fecv
induc
mild
enter
cat
note
base
genet
antigen
comparison
fipv
fecv
belong
one
felin
coronaviru
fcov
group
broad
rang
pathogen
rather
consid
viru
independ
entiti
consid
due
reduc
immun
host
cat
mutat
fecv
fipv
occur
host
mutat
viru
induc
fip
gener
macrophag
play
import
role
nonspecif
defens
viral
infect
howev
also
known
virus
bound
antibodi
invad
macrophag
via
fc
region
antibodi
fc
gamma
receptor
macrophag
eventu
antibodi
lead
enhanc
infect
dengu
hemorrhag
feverdengu
shock
syndrom
caus
infect
mechan
phenomenon
call
antibodi
depend
enhanc
ade
viru
infect
antibodi
fipv
also
known
enhanc
fipv
infect
acceler
diseas
onset
cat
follow
experiment
fipv
infect
cat
fipvneutr
antibodi
frequent
develop
fip
rapidli
sever
seroneg
cat
fipv
virion
consist
main
structur
protein
nucleocapsid
protein
n
small
integr
membran
glycoprotein
larg
spike
glycoprotein
previous
report
vitro
fipv
infect
felin
alveolar
macrophag
enhanc
murin
mab
protein
fipv
ade
activ
increas
mab
show
neutral
activ
felin
kidney
cell
crfk
suggest
distinct
correl
ade
activ
neutral
activ
ade
activ
depend
mous
mab
ig
subclass
depend
close
correl
abil
antibodi
bind
felin
macrophag
even
among
mab
shown
recogn
antigen
site
mab
strongli
enhanc
fipv
infect
wherea
mab
close
associ
enhanc
neutral
epitop
obstacl
develop
vaccin
contain
neutral
epitop
without
enhanc
epitop
detail
analysi
expect
studi
prepar
unusu
mab
show
cell
tropism
neutral
activ
fipv
infect
mab
show
strong
neutral
activ
felin
macrophag
without
ade
activ
despit
belong
subclass
howev
antibodi
exhibit
neutral
activ
felin
fibroblastoid
cell
line
crfk
cell
fipv
strain
obtain
dr
c
horzinek
state
univers
utrecht
netherland
crfk
cell
feli
catu
whole
fetu
cell
felin
alveolar
macrophag
cultur
eagl
minimum
essenti
medium
mem
contain
leibovitz
medium
fetal
calf
serum
unitsml
penicillin
gml
streptomycin
mainten
medium
mem
contain
antibiot
felin
alveolar
macrophag
collect
adult
cat
neg
anticoronaviru
antibodi
describ
previous
viru
antigen
prepar
fipv
strain
grownin
cell
cultur
infecti
cultur
fluid
concentr
nearli
tenfold
ammonium
sulfat
precipit
layer
onto
discontinu
sucros
densiti
gradient
rp
roter
hitachi
koki
co
ltd
japan
centrifug
rpm
h
viru
band
form
collect
dilut
nte
buffer
nacl
trishcl
ph
edta
centrifug
g
h
viruscontain
pellet
suspend
volum
nte
buffer
treat
triton
c
h
mab
use
mab
recogn
protein
mab
mab
use
mab
recogn
protein
n
protein
respect
among
mab
mab
neutral
activ
crfk
cell
furthermor
mab
mous
antibodi
exhibit
neutral
activ
felin
macrophag
howev
mab
show
strong
ade
activ
felin
macrophag
belong
subclass
prepar
mab
fipv
strain
balbc
mice
week
age
inocul
intraperiton
mixtur
g
viru
antigen
prepar
describ
cell
pertussi
adjuv
four
week
later
mice
receiv
intraven
booster
dose
g
viral
antigen
spleen
cell
obtain
fusion
day
later
fusion
carri
essenti
method
describ
milstein
merck
feder
republ
germani
use
fuse
agent
ratio
mous
spleen
cell
mous
myeloma
cell
select
medium
contain
hypoxanthin
aminopterin
thymidin
fuse
cell
concentr
spleen
cell
per
ml
dispend
l
volum
flatbottom
micropl
corn
glass
work
corn
ny
incub
c
humid
atmospher
contain
co
incub
week
well
examin
contain
hybridoma
cultur
test
felin
coronaviru
specif
antibodi
indirect
fluoresc
antibodi
ifa
assay
see
coloni
antibodyposit
well
passag
multipl
corn
glass
work
corn
ny
incub
medium
contain
hypoxanthin
thymidin
cell
clone
soft
agar
method
supernat
fluid
antibodysecret
hybridoma
cultur
concentr
tenfold
satur
ammonium
sulfat
use
determin
antibodi
class
subclass
doubl
diffus
agar
gel
contain
nan
rabbit
antisera
mous
immunogloblin
igm
iga
place
center
well
test
sampl
ad
adjac
well
plate
incub
overnight
room
temperatur
humidifi
chamber
polypeptid
recogn
mab
purifi
viru
antigen
prepar
describ
affin
chromatographi
use
hitrap
nhsactiv
affin
column
pharmacia
biotech
sweden
accord
manufactur
protocol
ligand
igg
purifi
mous
ascit
fluid
mab
protein
asepharos
pharmacia
biotech
sweden
use
molecular
weight
purifi
polypeptid
determin
western
immunoblot
viral
antigen
separ
polyacrylamid
gel
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
transfer
nitrocellulos
sheet
g
pore
size
transfer
carri
electrophoret
method
adapt
describ
towbin
et
al
transferblot
cell
apparatu
v
h
use
transfer
buffer
consist
gl
tri
ph
methanol
gl
glycin
nitrocellulos
sheet
cut
strip
incub
c
h
pb
contain
fetalcalf
serum
supernat
fluid
antibodysecret
hybridoma
cultur
ad
ml
volum
individu
strip
incub
c
h
strip
wash
time
pb
contain
incub
c
h
horseradish
peroxidaseconjug
rabbit
antibodi
mous
igg
mile
lab
usa
dilut
pb
contain
fetal
calf
serum
strip
wash
treat
substrat
solut
contain
g
diaminobenzidin
l
h
ml
trishcl
ph
distinct
band
appear
min
later
reaction
stop
pour
substrat
solut
rins
distil
water
hybridoma
cultur
supernat
fluid
ad
acetonefix
fipvinfect
cell
incub
min
c
wash
time
phosphat
buffer
salin
solut
pb
stain
rabbit
antimouseigg
serum
conjug
fluorescein
isothiocyan
fitc
mile
lab
usa
min
incub
c
slide
wash
pb
stain
cell
mount
buffer
glycerol
examin
use
fluoresc
microscop
neutral
test
perform
use
cell
crfk
cell
felin
macrophag
viral
solut
fipv
strain
adjust
tcid
use
cell
crfk
cell
viral
solut
adjust
tcid
use
felin
macrophag
equal
volum
viru
mab
mix
react
cell
crfk
cell
c
felin
macrophag
c
min
reaction
mixtur
ad
cell
crfk
cell
felin
macrophag
viral
absorpt
c
min
reaction
solut
remov
aspir
mainten
medium
ad
cell
incub
c
day
cell
crfk
cell
neutral
antibodi
titer
express
reciproc
highest
dilut
mab
complet
inhibit
cytopath
effect
test
felin
macrophag
viral
proteinspecif
fluoresc
measur
ifa
method
estim
infect
rate
infect
rate
obtain
follow
formula
infect
rate
b
ifa
posit
rate
presenc
antibodi
b
ifa
posit
rate
absenc
antibodi
infect
rate
lower
indic
neutral
activ
infect
rate
higher
indic
enhanc
activ
cell
fusion
perform
use
spleen
cell
mous
immun
viral
antigen
hybridoma
cell
produc
antibodi
ifaposit
fipv
select
neutral
activ
hybridoma
cultur
strain
examin
use
cell
crfk
cell
felin
macrophag
mab
show
neutral
activ
felin
macrophag
obtain
nt
test
result
felin
macrophag
shown
fig
result
cell
crfk
cell
shown
tabl
neither
mab
cultur
supernat
mab
mous
ascit
show
neutral
activ
cell
crfk
cell
contrast
mab
show
strong
neutral
activ
show
enhanc
activ
felin
macrophag
mab
use
control
show
neutral
activ
cell
type
mab
show
neutral
activ
cell
crfk
cell
show
strong
enhanc
activ
felin
macrophag
specif
mab
fipv
strain
polypeptid
investig
western
immunoblot
mab
specif
react
n
viral
structur
protein
data
shown
therefor
attempt
purifi
polypeptid
recogn
mab
affin
chromatographi
mab
immobil
hitrap
nhsactiv
affin
column
pharmacia
biotech
sweden
viral
antigen
load
column
bound
polypeptid
elut
mab
purifi
polypeptid
investig
western
immunoblot
mab
infect
rate
calcul
describ
materi
method
neutral
titer
b
balbc
inject
intraperiton
ml
pristan
day
intraperiton
inocul
hybridoma
cell
ten
day
later
ascit
fluid
collect
clarifi
centrifug
store
c
use
repres
molecular
weight
marker
recogn
fipv
n
protein
respect
use
detect
polypeptid
recogn
mab
polypeptid
recogn
mab
specif
react
mab
recogn
protein
fig
find
strongli
suggest
viral
structur
protein
recogn
mab
protein
although
ig
subclass
mab
prevent
fipv
strain
infect
felin
macrophag
therefor
felin
macrophag
pretreat
mab
prior
fipv
inocul
effect
neutral
activ
fipv
infect
examin
result
felin
macrophag
pretreat
mab
belong
subclass
use
control
neutral
activ
disappear
contrast
mab
neutral
fipv
mixtur
viru
antibodi
inocul
felin
macrophag
fig
furthermor
mab
also
belong
subclass
mab
show
strong
enhanc
activ
viru
premix
antibodi
inocul
neutral
activ
mab
confirm
act
via
antibodi
fc
region
macrophag
fcgr
protein
atreat
mab
ad
felin
macrophag
incub
c
h
wash
hbss
cell
inocul
viru
result
protein
atreat
complet
lost
neutral
activ
fig
fipv
absorb
felin
macrophag
c
h
cell
react
mab
effect
neutral
activ
investig
mab
show
strong
neutral
activ
felin
macrophag
use
control
result
mab
prevent
fipv
infect
mab
fig
studi
succeed
obtain
mab
prevent
fipv
strain
infect
felin
macrophag
despit
belong
subclass
howev
mab
neutral
fipv
infect
cell
crfk
cell
show
unusu
properti
sinc
mab
specif
react
fipvinfect
cell
ifa
assay
obviou
mab
recogn
fipv
antigen
data
shown
howev
specif
reaction
detect
western
immunoblot
use
purifi
fipv
antigen
probabl
mab
recogn
region
recogn
tertiari
structur
chang
fipv
antigen
denatur
sd
therefor
polypeptid
recogn
mab
purifi
affin
chromatographi
polypeptid
specif
examin
western
immunoblot
known
mab
recogn
n
protein
purifi
polypeptid
specif
react
mab
recogn
protein
find
strongli
suggest
polypeptid
recogn
contain
protein
known
felin
macrophag
pretreat
mab
neutral
activ
cell
crfk
cell
inocul
fipv
wash
antibodi
show
strong
enhanc
activ
howev
mab
show
neutral
activ
even
felin
macrophag
pretreat
mab
inocul
fipv
mab
use
control
show
neutral
activ
method
although
show
strong
neutral
activ
method
virusantibodi
mixtur
inocul
felin
macrophag
conclud
mab
could
bind
felin
macrophag
fcgr
mab
remov
wash
contrast
mab
may
remov
wash
due
strong
bind
felin
macrophag
fcgr
express
neutral
activ
protein
atreat
mab
examin
experi
neutral
activ
lost
consid
protein
bound
mab
fc
region
block
bind
felin
macrophag
fcgr
furthermor
mab
show
neutral
activ
even
antibodi
ad
felin
macrophag
inocul
fipv
find
suggest
mab
act
cell
fipv
absorpt
cell
prevent
infect
antibodi
exhibit
neutral
activ
viral
absorpt
cell
also
report
herp
simplex
viru
adenoviru
antiherp
simplex
viru
glycoproteind
mab
exhibit
neutral
activ
viral
absorpt
cell
similarli
mab
neutral
activ
also
detect
antiadenoviru
penton
antiserum
method
although
neutral
mechan
clarifi
may
express
neutral
activ
via
mechan
antibodi
furthermor
confirm
studi
mab
recogn
protein
coronaviru
protein
thought
play
import
role
viral
bud
cell
viral
bud
occur
viral
structur
protein
synthesi
fipv
react
mab
inocul
felin
macrophag
fipv
antigen
detect
cell
ifa
assay
indic
fipv
neutral
mab
synthes
viral
protein
therefor
conclud
neutral
exert
block
certain
step
fipv
replic
cycl
fusion
cellular
viral
membran
translat
analysi
mechan
necessari
sinc
mab
show
cell
tropism
neutral
activ
possibl
fipv
replic
manner
differ
cell
felin
macrophag
also
requir
investig
prepar
antim
protein
mab
neutral
fipv
infect
cell
crfk
cell
yet
report
howev
horzinek
et
al
suggest
antim
protein
antibodi
complementrequir
neutral
activ
previous
report
certain
proteinrecogn
mab
enhanc
activ
howev
vennema
et
al
found
inject
fipv
cat
vaccin
recombin
vaccinia
vaccin
express
protein
fip
onset
advanc
cat
immun
recombin
vaccinia
viru
express
protein
three
eight
cat
immun
recombin
vaccinia
viru
express
protein
surviv
diseas
onset
advanc
enhanc
activ
mab
protein
report
weak
compar
mab
recogn
protein
mani
unclear
point
role
protein
host
immun
fipv
infect
investig
necessari
report
mab
show
fipvneutr
activ
induc
enhanc
activ
felin
macrophag
indic
neutral
epitop
enhanc
epitop
fipv
locat
close
site
howev
mab
show
neutral
activ
felin
macrophag
despit
belong
subclass
find
strongli
suggest
presenc
new
epitop
prevent
fipv
infect
felin
macrophag
fipv
infect
felin
macrophag
thought
import
develop
fip
identif
epitop
recogn
may
allow
develop
vaccin
prevent
diseas
develop
